{"retracted":false,"update":{"timestamp":1490659200000,"doi":"10.1007/s11523-017-0483-8","type":"correction"},"doi":"10.1007/s11523-015-0410-9","journal":"Targeted Oncology","publisher":"Springer Nature","title":"Erratum to: Ongoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case Report"}
